Latest Senores Pharmaceuticals stock price

Senores Pharmaceuticals P/E Ratio

SENORES • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
34.6
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 34.6
Current Price ₹766.00
EPS (TTM) ₹16.12
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 26.51
Historical Range 25.69 - 27.33
Percentile 100.0%

Sector Context

Sector Average 48.19
Sector Median 27.3
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹22.24
Sept 2025 ₹6.54
Mar 2025 ₹3.81

Key P/E Ratio Insights for Senores Pharmaceuticals

  • Stock appears overvalued with PE of 34.6, suggesting caution for new investments
  • Current PE is 30.5% above historical average
  • Trading at discount to sector average PE of 48.19

View the SENORES equity price for detailed stock performance.

P/E Ratio Historical Trend for Senores Pharmaceuticals

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 25.69 22.24 ₹571.30 NSE High
2024 27.33 20.38 ₹557.05 NSE High

Sector P/E Ratio Comparison

Comparing Senores Pharmaceuticals with other companies in Healthcare sector
Sector Average
48.19
Sector Median
27.3
Lowest P/E
1.1
Highest P/E
754.17
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.1 ₹38 Low
Murae Organisor MURAE 3.14 ₹47 Low
Ind Swift Laboratories INDSWFTLAB 4.87 ₹1,186 Low
Amwill Health Care AMWILL 6.5 ₹67 Low
Medicamen Organics MEDIORG 6.94 ₹27 Low
JFL Life Sciences JFLLIFE 7.53 ₹36 Low
Galaxy Medicare GML 7.66 ₹26 Low
Unichem Laboratories UNICHEMLAB 8.42 ₹2,437 Low
Zenith Drugs ZENITHDRUG 9.03 ₹85 Low
Brooks Laboratories BROOKS 9.44 ₹198 Low